About GiveVision
About GiveVision
One in three people will lose their sight by the age of 65. For many of us, it is not a question of if, but a matter of how soon.
We have witnessed first-hand the devastating effects of severe sight loss, and founded GiveVision in 2014 with the aim of developing a wearable vision aid that could transform the lives of people with severe sight impairments.
Inspired by the latest developments in augmented and virtual reality technology, we set out to create a device which would allow people with sight loss to regain much of their sight.
Our mission is to create a world where everyone can see.
We have witnessed first-hand the devastating effects of severe sight loss, and founded GiveVision in 2014 with the aim of developing a wearable vision aid that could transform the lives of people with severe sight impairments.
Inspired by the latest developments in augmented and virtual reality technology, we set out to create a device which would allow people with sight loss to regain much of their sight.
Our mission is to create a world where everyone can see.
One in three people will lose their sight by the age of 65. For many of us, it is not a question of if, but a matter of how soon.
We have witnessed first-hand the devastating effects of severe sight loss, and founded GiveVision in 2014 with the aim of developing a wearable vision aid that could transform the lives of people with severe sight impairments.
Inspired by the latest developments in augmented and virtual reality technology, we set out to create a device which would allow people with sight loss to regain much of their sight.
Our mission is to create a world where everyone can see.
We have witnessed first-hand the devastating effects of severe sight loss, and founded GiveVision in 2014 with the aim of developing a wearable vision aid that could transform the lives of people with severe sight impairments.
Inspired by the latest developments in augmented and virtual reality technology, we set out to create a device which would allow people with sight loss to regain much of their sight.
Our mission is to create a world where everyone can see.
Leadership Team
Prof Marc Robert Clement
Board Chairman, interim Chief Science Officer
Marc is a renowned academic, inventor and entrepreneur in the field of Life Science and Medical Technology. Vice Chancellor and Chief Executive of the University of Wales (2007 - 2012), Marc is the author and inventor of over 50 patents and has founded many medical technology companies. He has served on the Boards of numerous UK companies and several NASDAQ companies
Marc has been directly responsible for raising in excess of £200m investment in the public and private sector endeavours. He is widely recognised as the architect of the £1.3bn Swansea Bay City Region Deal signed by the Prime Minister in 2018.
PhD in Laser Technology, Marc is a chartered engineer, chartered physicist, Fellow of the Institute of Physics and Fellow of the Institute of Engineering and Technology. He is also a founding Fellow of the Learned Society of Wales.
He has now retired from academic life and is pursuing a career as an entrepreneur and innovator in life science.
Marc has been directly responsible for raising in excess of £200m investment in the public and private sector endeavours. He is widely recognised as the architect of the £1.3bn Swansea Bay City Region Deal signed by the Prime Minister in 2018.
PhD in Laser Technology, Marc is a chartered engineer, chartered physicist, Fellow of the Institute of Physics and Fellow of the Institute of Engineering and Technology. He is also a founding Fellow of the Learned Society of Wales.
He has now retired from academic life and is pursuing a career as an entrepreneur and innovator in life science.
Dr Soulaiman Itani
Director of Hardware Development & AI
Soulaiman Itani is a founder of Atheer - a pioneering company in AR, that created the world's first mobile holographic interaction smart glasses. Atheer, created the first mobile natural interaction AR glasses controlled by gestures, voice, and motion.
Under Soulaiman's leadership, Atheer raised more than $40M in funding from Silicon Valley and grew to a market leader in AR, generating multi-million revenues.
Thanks to Soulaiman's vision and aggressive IP strategy, Atheer today, is at the centre of the AR SW for the enterprise. It's patented SW suite is pre-installed on many market leading OEM AR hardware and is a default operating system for B2B AR solutions.
MIT/Berkeley trained with a Ph.D. in Electrical Engineering and Computer Science, holding more than 40 patents in AR, VR, vision ergonomics, Computer Vision and Machine Learning, and AI
Soulaiman brings to our board his experience and proven ability to create cutting edge technology and IP, design and implement new business models, develop strategic partnerships, and negotiate and sign multi-million dollar deals with F100 companies.
Under Soulaiman's leadership, Atheer raised more than $40M in funding from Silicon Valley and grew to a market leader in AR, generating multi-million revenues.
Thanks to Soulaiman's vision and aggressive IP strategy, Atheer today, is at the centre of the AR SW for the enterprise. It's patented SW suite is pre-installed on many market leading OEM AR hardware and is a default operating system for B2B AR solutions.
MIT/Berkeley trained with a Ph.D. in Electrical Engineering and Computer Science, holding more than 40 patents in AR, VR, vision ergonomics, Computer Vision and Machine Learning, and AI
Soulaiman brings to our board his experience and proven ability to create cutting edge technology and IP, design and implement new business models, develop strategic partnerships, and negotiate and sign multi-million dollar deals with F100 companies.
Alex Shlyankevich
Board Director, Clinical & Commercial
Background in brand and generic pharmaceutical, biotech, drug delivery, medical devices, service, contract pharma, and start-up companies with hands-on technical and managerial leadership experience in CMC sciences and operations throughout drug life cycle.
Contributor to multiple successful drug development programs, regulatory filings and product launches with thorough understanding of compliance, business and budgetary aspects of CMC operations. Hands-on experience in dealing with the FDA and BfArM during submission, approval and commercial stages.
Track record of solving CMC-related problems in product development using multidisciplinary approach. Achievements in cross-functional and international facilitation, program leadership, collaboration management, business and capabilities presentation, and start-up organization growth. Extensive practical knowledge of outsourcing as a client and service provider.
Contributor to multiple successful drug development programs, regulatory filings and product launches with thorough understanding of compliance, business and budgetary aspects of CMC operations. Hands-on experience in dealing with the FDA and BfArM during submission, approval and commercial stages.
Track record of solving CMC-related problems in product development using multidisciplinary approach. Achievements in cross-functional and international facilitation, program leadership, collaboration management, business and capabilities presentation, and start-up organization growth. Extensive practical knowledge of outsourcing as a client and service provider.
Stan Karpenko
Co-founder & CEO
Stan co-founded GiveVision in 2014, using the proceeds from selling his previous venture (YieldPartner.com) and developed the company until it was in a position to raise almost $2 million of non-dilutive funding from innovation agencies and government research grants. Stan has since led GiveVision to become one of UK's leading health-tech start-ups.
In his role as CEO, Stan has led product development as well as the R&D of all GiveVision's underlying technologies. He has built and led the cross-disciplinary team with niche expertise in AR, wearable hardware development, camera technologies, optical engineering, industrial design and manufacturing; and secured strategic industry partnerships and funding from Pfizer, Telefonica, and the NHS.
In his role as CEO, Stan has led product development as well as the R&D of all GiveVision's underlying technologies. He has built and led the cross-disciplinary team with niche expertise in AR, wearable hardware development, camera technologies, optical engineering, industrial design and manufacturing; and secured strategic industry partnerships and funding from Pfizer, Telefonica, and the NHS.
George Henry Hines
VP of Hardware Engineering
George has and extensive experience in both product development and operational management, with significant emphasis in consumer and wireless products. Has a proven track record of engineering and manufacturing consumer electronic devices from concept - to - scale.
Over the last 15 years, George has worked on some of his most complex breakthrough consumer hardware products including the worlds thinnest laptop from DELL, first dual screen smartphone, IP68 intrinsically safe smartphones and AR / Head Mounted Display devices.
George's key strengths are: his rare expertise of combining electronic engineering, optical design and industrial design to manufacture wearable AR devices, as well as his experience of working with new materials and manufacturing processes to design consumer electronic products.
Over the last 15 years, George has worked on some of his most complex breakthrough consumer hardware products including the worlds thinnest laptop from DELL, first dual screen smartphone, IP68 intrinsically safe smartphones and AR / Head Mounted Display devices.
George's key strengths are: his rare expertise of combining electronic engineering, optical design and industrial design to manufacture wearable AR devices, as well as his experience of working with new materials and manufacturing processes to design consumer electronic products.
Piotr Imelski
Co-founder, Head of Software Engineering
Key software engineer behind all of the GiveVision's software assets. Has designed and implemented our proprietary computer vision processing algorithms that allowed for low-power image processing, unrivalled for its speed and efficiency.
Over his 30-year career in software, Piotr has worked as a Senior Software Engineer on complex government and corporate projects and has experience of developing software products across large and micro teams. C++, Java, OpenGL, php, JAVAScript; Android, Linux, Kernel and cloud database systems.
Over his 30-year career in software, Piotr has worked as a Senior Software Engineer on complex government and corporate projects and has experience of developing software products across large and micro teams. C++, Java, OpenGL, php, JAVAScript; Android, Linux, Kernel and cloud database systems.
Elodie Draperi
Co-founder, Head of Customer Development
As head of UI/UX, Elodie conducted prototype evaluation interviews with over 1000 patients and led the development of our "one-touch" user interface, which enabled patients as old as 96, with almost no sight, to learn and use the SightPlus device independently within minutes!
Elodie has built a pipeline of 3,000 patients, developed a customer conversion funnel, as well as led on a number of key corporate partnerships and relationships with clinical community.
Elodie led on the design of user trials and experiments that validated Product-Market-Fit and clinical benefit of the technology as well as built strategic relationships with world-leading institutions, including Moorfield's Eye Hospital.
Elodie has built a pipeline of 3,000 patients, developed a customer conversion funnel, as well as led on a number of key corporate partnerships and relationships with clinical community.
Elodie led on the design of user trials and experiments that validated Product-Market-Fit and clinical benefit of the technology as well as built strategic relationships with world-leading institutions, including Moorfield's Eye Hospital.
Eugenie Golubova
Head of Regulatory, Quality and Compliance
Eugenie leads on all regulatory, compliance and quality management areas of the business making sure we operate to the highest medical grade quality standards (ISO13485) and comply with international and federal regulations.
She has successfully led the company through CE medical device registration process in Europe.
Graduate of the London School of Economics (with merit) Eugenie speaks five languages, and in her previous career as a researcher she worked for a variety of clients including the European Commission.
She has successfully led the company through CE medical device registration process in Europe.
Graduate of the London School of Economics (with merit) Eugenie speaks five languages, and in her previous career as a researcher she worked for a variety of clients including the European Commission.
The team at HMD-Tech
A French enterprise, based in Lille, is experienced in the fields of virtual reality, mobile app development, product design and manufacturing.
They sold more than 1 million units worldwide since our inception and they created the True-Immersion OpticsTM for quality lenses in our head-mounted displays to offer the best visual experience.
With us, they are eager to tackle the technical challenges of mixed reality in order to build better low vision aids, as well as implementing innovative ways to facilitate the access of those solutions in the French market
With us, they are eager to tackle the technical challenges of mixed reality in order to build better low vision aids, as well as implementing innovative ways to facilitate the access of those solutions in the French market
Leadership Team
Prof Marc Robert Clement
Board Chairman, interim Chief Science Officer
Dr Soulaiman Itani
Director of Hardware Development & AI
Alex Shlyankevich
Board Director, Clinical & Commercial
Stan Karpenko
Co-founder & CEO
George Henry Hines
VP of Hardware Engineering
Piotr Imelski
Co-founder, Head of Software Engineering
Elodie Draperi
Co-founder, Head of Customer Development
Eugenie Golubova
Head of Regulatory, Quality and Compliance
The team at HMD-Tech
A French enterprise, based in Lille, is experienced in the fields of virtual reality, mobile app development, product design and manufacturing.
Scientific & Clinical Expertise
Antonin (Tony) de Fougerolles
CEO of Evox, CSO at Ablynx & Moderna
Currently CEO of Evox Therapeutics, Tony has over 20 years of biotech R&D experience in creating transformative treatments for patients. He has played a key role in developing and successfully advancing 3 new drug modalities towards the market and in helping build several multi-billion dollar companies from start-up stage.
Dr Mike Short CBE
Chief Scientific Adviser, Department for International Trade (DIT)
Mike leads the science and engineering profession in the department and ensures its policy is informed by the best science, engineering and technical advice. He advises on the technical aspects of future trade deals as DIT looks to create new arrangements following Brexit, and works with the UK's research, development and academic communities to boost scientific and engineering exports.
Mike has over 40 years' experience in electronics and telecommunications and served as Vice President of Telefonica, the parent company of the O2 mobile phone network, for 17 years. In this post, he managed the launch of 2G (GSM) and 3G mobile technologies in the UK, and led research and development for Telefonica Europe.
Former Chairman of the Global GSM Association, the UK Mobile Data Association, and president of the Institution of Engineering and Technology.
Mike has over 40 years' experience in electronics and telecommunications and served as Vice President of Telefonica, the parent company of the O2 mobile phone network, for 17 years. In this post, he managed the launch of 2G (GSM) and 3G mobile technologies in the UK, and led research and development for Telefonica Europe.
Former Chairman of the Global GSM Association, the UK Mobile Data Association, and president of the Institution of Engineering and Technology.
Dr Nevan Clancy Hanumara
Research Scientist, Massachusetts Institute of Technology (MIT)
Dr. Hanumara is a Research Scientist in MIT Mechanical Engineering's Precision Engineering Research Group where he leads the group's healthcare design effort
He co-instruct MIT's Medical Device Design course, which fosters clinical-engineering and focuses on human-centered design, with application in clinical settings.
Nevan holds a PhD and MS in Mechanical engineering from MIT and a BS in Mechanical Engineering and BA in French from the University of Rhode Island's International Engineering Program.
He co-instruct MIT's Medical Device Design course, which fosters clinical-engineering and focuses on human-centered design, with application in clinical settings.
Nevan holds a PhD and MS in Mechanical engineering from MIT and a BS in Mechanical Engineering and BA in French from the University of Rhode Island's International Engineering Program.
Dr Hamish Graham
London manager for the Pfizer Healthcare Hub and a practicing surgeon
Hamish runs The Pfizer Healthcare hubs - are a global network, designed to help innovators transform the lives of more patients and healthcare practitioners.
As Pfizer Healthcare Hub London lead, Hamish's role is to connects innovators in digital healthcare with patients, healthcare practitioners, healthcare leaders and industry experts from Pfizer to VCs.
As Pfizer Healthcare Hub London lead, Hamish's role is to connects innovators in digital healthcare with patients, healthcare practitioners, healthcare leaders and industry experts from Pfizer to VCs.
Scientific & Clinical Expertise
Antonin (Tony) de Fougerolles
CEO of Evox, CSO at Ablynx & Moderna
Dr Mike Short CBE
Chief Scientific Adviser, Department for International Trade (DIT)
Dr Nevan Clancy Hanumara
Research Scientist, Massachusetts Institute of Technology (MIT)
Dr Hamish Graham
London manager for the Pfizer Healthcare Hub and a practicing surgeon
Investing in vision:
Meet the organisations who funded the development of this technology:
GiveVision CAREERS
Your talent here.
At GiveVision we are creating a platform for enhancing human vision and achievement. Does your background include product design, user experience, applied physics, hardware, software, optics, photonics, electronics, chemistry, biology, or vision science? If so, we should talk.
Our Supporters:
Product
CLINICAL DATA
Help